Janney Montgomery Scott
PACB icon

Janney Montgomery Scott’s Pacific Biosciences PACB Stock Holding History

Janney Montgomery Scott’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,350
Closed -$12K – 2799
2025
Q1 		$12K Buy
+10,350
New +$15.9K ﹤0.01% 2657
2022
Q2 		– Sell
-10,030
Closed -$91K – 2405
2022
Q1 		$91K Sell
10,030
-18,592
-65% -$214K ﹤0.01% 2188
2021
Q4 		$586K Sell
28,622
-86
-0.3% -$2.08K ﹤0.01% 1625
2021
Q3 		$733K Buy
28,708
+1,904
+7% +$56.4K ﹤0.01% 1443
2021
Q2 		$937K Buy
26,804
+4,034
+18% +$117K ﹤0.01% 1299
2021
Q1 		$758K Buy
22,770
+4,006
+21% +$140K ﹤0.01% 1339
2020
Q4 		$487K Buy
+18,764
New +$319K ﹤0.01% 1586

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janney Montgomery Scott's PACB Position: Q2 2025 in Review

Janney Montgomery Scott sold out of Pacific Biosciences (PACB) in Q2 2025, closing a stake of 10,350 shares — an estimated $12K sold.

Janney Montgomery Scott first reported a position in PACB in Q4 2020 and held it in 7 quarters. The position peaked at $937K in Q2 2021. 207 funds tracked by Wall St. Rank hold PACB as of Q2 2025.

  • Janney Montgomery Scott reported no remaining Pacific Biosciences position as of Q2 2025 after selling out during the quarter.
  • Janney Montgomery Scott sold 10,350 Pacific Biosciences shares in Q2 2025, an estimated $12K.
  • Janney Montgomery Scott first reported a position in Pacific Biosciences in Q4 2020 and held it in 7 quarters.
  • Janney Montgomery Scott's Pacific Biosciences position peaked at $937K in Q2 2021.
  • 207 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2025.

Based on Janney Montgomery Scott's 13F filing for Q2 2025, filed 17 Jul 2025.